Large cohort study confirms link between pioglitazone, bladder cancer

Pioglitazone was linked to a 63% increase in bladder cancer risk, compared with other noninsulin antidiabetic drugs in a large population-based cohort study. Furthermore, incidence rose the longer...
Source: Family Practice News - Category: Primary Care Source Type: news